iifl-logo

Glenmark Pharmaceuticals Ltd Historical Data

Add as a Preferred Source on Google
2,450
(0.11%)
Sep 21, 2026|03:52:58 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Glenmark Pharmaceuticals Ltd Historical Data

21/08/2026calendar-icon
21/09/2026calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

24-Aug-2026

2,315.1

2,3952,295.32,390.747,7121,67,42,87,111.13,08,428

25-Aug-2026

2,391.7

2,4212,3762,40065,3811,56,75,72,135.92,78,136

26-Aug-2026

2,392.2

2,457.52,384.52,438.329,5181,16,92,93,219.51,79,829

27-Aug-2026

2,455

2,4842,440.62,46036,3201,09,94,11,359.52,00,850

28-Aug-2026

2,460

2,537.62,431.72,51553,1592,01,03,40,569.13,95,151

31-Aug-2026

2,532.4

2,532.42,4522,48039,6192,25,92,29,272.14,88,059

01-Sep-2026

2,480

2,494.92,4552,470.433,3971,68,08,82,218.12,52,951

02-Sep-2026

2,455

2,476.92,4202,46026,7991,26,21,81,585.62,72,139

03-Sep-2026

2,470

2,471.82,425.12,45934,2851,17,34,04,986.62,76,270

04-Sep-2026

2,454.5

2,456.72,422.72,437.225,3421,00,54,01,462.62,37,692

07-Sep-2026

2,420.2

2,4722,420.22,451.929,29465,68,89,629.71,09,229

08-Sep-2026

2,469.9

2,4922,4392,474.546,9521,10,58,26,494.52,19,743

09-Sep-2026

2,486.9

2,486.92,400.12,43534,8911,03,21,44,201.11,59,072

10-Sep-2026

2,445.9

2,449.92,403.12,41525,79263,48,89,477.21,51,319

11-Sep-2026

2,411.2

2,431.92,384.12,419.234,93983,71,67,783.51,54,001

15-Sep-2026

2,420.8

2,429.82,346.62,371.730,41865,74,83,3231,41,296

16-Sep-2026

2,371.7

2,425.82,306.32,41043,7371,60,38,65,678.33,13,621

17-Sep-2026

2,406.8

2,416.92,388.42,41619,96454,63,34,330.41,01,278

18-Sep-2026

2,409.8

2,447.42,396.82,447.427,9021,32,00,67,761.93,62,810

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.